CN101307027B - 一种阿那曲唑的新的制备方法 - Google Patents
一种阿那曲唑的新的制备方法 Download PDFInfo
- Publication number
- CN101307027B CN101307027B CN2007100686266A CN200710068626A CN101307027B CN 101307027 B CN101307027 B CN 101307027B CN 2007100686266 A CN2007100686266 A CN 2007100686266A CN 200710068626 A CN200710068626 A CN 200710068626A CN 101307027 B CN101307027 B CN 101307027B
- Authority
- CN
- China
- Prior art keywords
- reaction
- formula
- dimethyl
- toluene
- anastrozole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC(C)(*)c1cc(C)cc(C(C)(C)*)c1 Chemical compound CC(C)(*)c1cc(C)cc(C(C)(C)*)c1 0.000 description 3
- OSEGNECCBMDWRB-UHFFFAOYSA-N CCC(C)(C)C#N Chemical compound CCC(C)(C)C#N OSEGNECCBMDWRB-UHFFFAOYSA-N 0.000 description 1
- ZWTWLMMVZLBAEX-UHFFFAOYSA-N CCC(C)(c1cc(C(C)(C)O)cc(C)c1)O Chemical compound CCC(C)(c1cc(C(C)(C)O)cc(C)c1)O ZWTWLMMVZLBAEX-UHFFFAOYSA-N 0.000 description 1
- DPKKOVGCHDUSAI-UHFFFAOYSA-N Cc1cc(Br)cc(Br)c1 Chemical compound Cc1cc(Br)cc(Br)c1 DPKKOVGCHDUSAI-UHFFFAOYSA-N 0.000 description 1
- NHAZGSRLKBTDBF-UHFFFAOYSA-N N[n]1ncnc1 Chemical compound N[n]1ncnc1 NHAZGSRLKBTDBF-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100686266A CN101307027B (zh) | 2007-05-17 | 2007-05-17 | 一种阿那曲唑的新的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100686266A CN101307027B (zh) | 2007-05-17 | 2007-05-17 | 一种阿那曲唑的新的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101307027A CN101307027A (zh) | 2008-11-19 |
CN101307027B true CN101307027B (zh) | 2011-09-07 |
Family
ID=40123733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100686266A Active CN101307027B (zh) | 2007-05-17 | 2007-05-17 | 一种阿那曲唑的新的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101307027B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102050775B (zh) * | 2009-11-11 | 2012-06-13 | 常州市第四制药厂有限公司 | 阿那曲唑杂质α,α,α′,α′-四甲基-5-(丁二酰亚胺-1-基甲基)-1,3-苯二乙腈及其制备方法 |
CN101973911B (zh) * | 2010-10-11 | 2013-11-06 | 中国科学技术大学 | 合成阿那曲唑中间体2,2’-(5-甲基-1,3-亚苯基)双(2-甲基丙腈)的方法 |
CN103524439B (zh) * | 2013-10-31 | 2015-07-15 | 哈药集团制药总厂 | 一种阿那曲唑的制备方法 |
CN103554041B (zh) * | 2013-11-12 | 2016-02-03 | 江苏正大清江制药有限公司 | 一种制备阿那曲唑的合成工艺 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0296749A1 (en) * | 1987-06-16 | 1988-12-28 | Zeneca Limited | (Substituted aralkyl) heterocyclic compounds |
WO2006000836A1 (en) * | 2004-06-24 | 2006-01-05 | Generics [Uk] Limited | Process for the preparation of anastrozole |
-
2007
- 2007-05-17 CN CN2007100686266A patent/CN101307027B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0296749A1 (en) * | 1987-06-16 | 1988-12-28 | Zeneca Limited | (Substituted aralkyl) heterocyclic compounds |
WO2006000836A1 (en) * | 2004-06-24 | 2006-01-05 | Generics [Uk] Limited | Process for the preparation of anastrozole |
Also Published As
Publication number | Publication date |
---|---|
CN101307027A (zh) | 2008-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101307027B (zh) | 一种阿那曲唑的新的制备方法 | |
CN105924355B (zh) | 沙库比曲中间体及沙库比曲中间体和沙库比曲的制备方法 | |
CN105263913A (zh) | 硫代1,2,4-三唑衍生物及其制备方法 | |
CN103965280A (zh) | 一种氟维司群中间体的制备方法 | |
CN102617587A (zh) | 一种2,3,6,7-三蝶烯四甲酸二酐的合成方法 | |
CN104109158A (zh) | 一种纯化利伐沙班的方法 | |
CN103483324B (zh) | 拉帕替尼的新制备方法 | |
CN109053525B (zh) | 一种(r)-2-(2-取代-5-氟苯)吡咯烷的制备方法 | |
CN105646285B (zh) | 一种维兰特罗中间体及其制备方法和应用 | |
CN104557748A (zh) | 硫代-1,2,4-三唑衍生物的新的固体形态 | |
CN111574444A (zh) | 一种贝达喹啉的制备方法 | |
CN113603670B (zh) | 一种制备1-(7-溴苯并并[d][1,3]二氧杂环戊烯-4-基)乙-1-酮的方法 | |
CN102245735B (zh) | 液晶化合物及其制备方法 | |
CN110407733A (zh) | 一种沙库巴曲杂质化合物 | |
CN103739614A (zh) | 氢化吡啶衍生物及其制备方法 | |
CN111116493B (zh) | 一种制备Apabetalone的方法、中间体及其中间体的制备方法 | |
CN105753735B (zh) | 一种高效低毒加压素拮抗药物的制备方法 | |
CN105153211B (zh) | 一种合成1‑(N‑Boc‑4‑哌啶)‑4‑吡唑硼酸频哪醇酯的方法 | |
CN103012477A (zh) | 一种制备三烷基膦氟硼酸盐的方法 | |
CN103781752A (zh) | 用于制造α-羟基酮化合物的方法 | |
CN109020895B (zh) | 一种金属催化的1-苄胺基取代苯并咪唑的合成方法 | |
CN105622413A (zh) | 2-[2-(2,4-二氟苯基)烯丙基]-1,3-丙二酸二乙酯的合成方法 | |
CN102086147B (zh) | 一种取代苯酚的制备方法 | |
CN104926847B (zh) | 一种合成硼胺类化合物工艺及产品应用 | |
CN106349229B (zh) | 雷迪帕韦中间体的制备方法及中间体化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HANGZHOU XINBOSI BIOLOGICAL MEDICINE CO., LTD. Free format text: FORMER OWNER: DU HUANDA Effective date: 20150320 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150320 Address after: Hangzhou City, Zhejiang province 310030 Xihu District three Town Xiyuan Road No. 8 Patentee after: HANGZHOU SIMBOS PHARM CO.,LTD. Address before: Hangzhou City, Zhejiang province Xihu District 310030 Park Road, No. 8 Patentee before: Du Huanda |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230322 Address after: 222000 No. 28 Lin Pu Road, Lianyungang economic and Technological Development Zone, Lianyungang, Jiangsu Patentee after: SINOPEP-ALLSINO BIOPHARMACEUTICAL Co.,Ltd. Address before: 310030 No. 8, Xiyuan 1st Road, Sandun Town, Xihu District, Hangzhou City, Zhejiang Province Patentee before: HANGZHOU SIMBOS PHARM CO.,LTD. |